Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIMERIX LIMITED Capital/Financing Update 2008

Jan 31, 2008

64804_rns_2008-01-31_6dd7522e-fa18-49da-b2c5-3d1693dc5897.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [228 x 84] intentionally omitted <==

ASX Company Announcement

1 February 2008

COMPLETION OF SHARE PURCHASE PLAN

Sun Biomedical Limited is pleased to announce completion of the Share Purchase Plan ( SPP ).

38 security holders have applied for 3,045,750 fully paid ordinary shares to raise $129,967.50.

As previously announced, the funds raised from the SPP will be primarily used to fund capital expenditure to increase manufacturing capacity, repayment of promissory note commitments and additional working capital.

It is anticipated that the Company’s Share Registry will dispatch new holding statements to shareholders on 1 February 2008.

For further information contact:

Andrew Paice Director Telephone: +61 3 8610 6370 Facsimile: +61 3 8610 6374 Email: [email protected]

Sun Biomedical Suite 401, 480 Collins Street, Melbourne, Victoria, Australia, 3000 Limited T: +61 3 8610 6370 | F: +61 3 8610 6374 | E: [email protected] ABN 18 001 285 230

ASX:SBN www.sunbiomed.com